Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Clinical trials could mark new era for pancreatic cancer treatment

(Getty Images)
(Getty Images)

A MULTIMILLION-POUND series of clinical trials in the UK could open up a new era of personalised treatment for pancreatic cancer, it is claimed.

The three trials, supported by £10 million in funding from the charity Cancer Research UK, are part of a major research project aimed at developing precision therapies for the deadly disease.

Pancreatic cancer has one of the worst cancer fatality rates, with only around 3% of sufferers expected to survive five years.

Each year around 9,600 Britons are diagnosed with the disease in the UK and more than 8,800 patients die.

The trials will recruit a total of 658 patients from centres across the UK. Scientists will use the molecular profile of each individual’s cancer to tailor personalised treatments.

Professor Andrew Biankin, from the University of Glasgow, who is co-leading the PRECISION Panc project, said: “I believe we’re on the cusp of making some incredible advances which will provide therapeutic options to help people affected by this terrible disease.”

Cancer Research UK is directly funding two of the trials, as well as pre-clinical work, the development of experimental procedures, and molecular sequencing.

Dr Ian Walker, the charity’s director of clinical research, said: “This ambitious project marks a new era for pancreatic cancer.

“Little progress has been made in outcomes for pancreatic cancer patients over the last 40 years, and we believe that PRECISION Panc will reshape how we approach treatment development.”

Funding and support has also come from the University of Glasgow, the Wellcome Trust, and the global biopharma company Celgene.